Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de valores de Sao Paulo  >  Fleury SA    FLRY3   BRFLRYACNOR5

FLEURY SA (FLRY3)
Mes dernières consult.
Most popular
  Report  
End-of-day quote. End-of-day quote  - 02/23
28.7 BRL   --.--%
01/29NOTICE TO THE M : Change in management
PU
2017FLEURY : Payment of Interest on Shareholders’ Equity
PU
2017MATERIAL FACT : Third Issue of Debentures
PU
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Notice to the market: Change in management

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/29/2018 | 10:09pm CET

FLEURY S.A.

Public Company CNPJ nº 60.840.055/0001-31

NIRE nº 35.300.197.534

Change in Management

São Paulo, January 29th, 2018 - In order to update its shareholders and the market in general, Fleury S.A. ("Company") hereby informs the approval and appointment, on this date, by the Board of Directors of Dr. Jeane Mike Tsutsui, previously Medical, Technical and Process Executive Officer, for the position of Fleury Brand Executive Officer.

The Company also hereby informs the approval and appointment by the Board of Directors of Dr. Edgar Gil Rizzati, previously Clinical Analysis Director, for the position of Medical, Technical and Process Executive Officer.

A brief profile of the two executive officers is available on our website: www.fleury.com.br/ir.

VIVIANE BEHAR DE CASTRO

Investors Relations Officer

Fleury SA published this content on 29 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 29 January 2018 21:08:25 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FLEURY SA
01/29NOTICE TO THE MARKET : Change in management
PU
2017FLEURY : Payment of Interest on Shareholders’ Equity
PU
2017MATERIAL FACT : Third Issue of Debentures
PU
2017NOTICE TO THE MARKET : Change in management
PU
2017NOTICE TO THE MARKET : resignation of members of the Board of Directors
PU
2017MATERIAL FACT : shares sale by a signatory of the Company´s shareholders´ agreem..
PU
2017NOTICE TO THE MARKET : Public Civil Action
PU
2017FLEURY : Call Notice to General Extraordinary Shareholders’ Meeting
PU
2017NOTICE TO THE MARKET : change in management
PU
2017FLEURY : Payment of dividends
PU
More news
News from SeekingAlpha
2017Fleury SA 2017 Q3 - Results - Earnings Call Slides 
Financials ( BRL)
Sales 2017 2 388 M
EBIT 2017 471 M
Net income 2017 319 M
Debt 2017 357 M
Yield 2017 1,55%
P/E ratio 2017 27,55
P/E ratio 2018 22,29
EV / Sales 2017 3,90x
EV / Sales 2018 3,41x
Capitalization 8 945 M
Chart FLEURY SA
Duration : Period :
Fleury SA Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | 4-Traders
Technical analysis trends FLEURY SA
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 32,6  BRL
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Carlos Alberto Iwata Marinelli Chief Executive Officer
Marcos Bosi Ferraz Chairman
Fernando Augusto Rodrigues Leão Filho Chief Financial Officer
Jeane Tsutsui Executive Director-Medical & Technical
Samuel Monteiro dos Santos Director
Sector and Competitors
1st jan.Capitalization (M$)
FLEURY SA-4.14%2 766
SONIC HEALTHCARE LIMITED5.34%7 983
DR. LAL PATHLABS LTD3.63%1 162
BML INC-2.54%1 107
NEOGENOMICS, INC.-6.88%650
CENTRO DE IMAGEM DIAGNOSTICOS SA3.65%560